Japanese startup seeks approval for cat kidney disease treatment
Founder says the company has filed for regulatory approval of a new treatment targeting chronic kidney disease in cats, a common condition with no definitive cure.
A Japanese startup has filed for approval of a new drug to treat chronic kidney disease in cats, the company's founder said on Monday. The filing offers hope for a common feline condition that currently has no definitive cure.